You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Payload

Showing 1 - 25 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in Sacramento, New Brunswick (RRx-001, Irinotecan)

Terminated
  • Malignant Solid Tumor
  • +2 more
  • Sacramento, California
  • +1 more
May 12, 2022

Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Port Saint Lucie, Florida
  • +1 more
Aug 11, 2023

Solid Tumor, Advanced Solid Tumor Trial (PYX-201)

Not yet recruiting
  • Solid Tumor
  • Advanced Solid Tumor
  • (no location specified)
Feb 9, 2023

Advanced Cancer Trial in Guangzhou (TQB2102 injection)

Not yet recruiting
  • Advanced Cancer
  • TQB2102 injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 23, 2023

Metastatic Solid Tumors, Esophageal Cancer, NSCLC Trial in Houston, San Antonio, Toronto (M1231)

Recruiting
  • Metastatic Solid Tumors
  • +2 more
  • Houston, Texas
  • +2 more
Jul 29, 2022

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting
  • Gastric Cancer
  • Small-cell Lung Cancer
  • Shanghai, Changning District, 交通大学 邮政编码, China
  • +20 more
Nov 1, 2022

Brain Metastases, Adult Trial in Durham (Patritumab deruxtecan)

Not yet recruiting
  • Brain Metastases, Adult
  • Patritumab deruxtecan
  • Durham, North Carolina
    Duke University Medical Center
Jan 19, 2023

Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

Recruiting
  • Ovarian Cancer
  • Lady Lake, Florida
  • +15 more
Mar 29, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

Recruiting
  • Brain Cancer
  • +4 more
  • Trastuzumab deruxtecan
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023

Healthy Volunteers Trial in Melbourne (Stelara, RT-111 (0.5mg), RT-111 (0.75mg))

Not yet recruiting
  • Healthy Volunteers
  • Melbourne, Australia
    Nucleus Network
Jun 5, 2023

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Advanced Solid Tumor Trial in Spain, United States (OMTX705, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
  • +7 more
Sep 16, 2022

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Gastric Cancer Trial in Philadelphia (Neratinib Pill, Fam-Trastuzumab Deruxtecan-Nxki (TDxD))

Suspended
  • Gastric Cancer
  • Neratinib Pill
  • Fam-Trastuzumab Deruxtecan-Nxki (TDxD)
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 6, 2022

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Multiple Myeloma, Plasma Cell Disorder Trial in Germany, United States (HDP-101)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Disorder
  • Atlanta, Georgia
  • +5 more
Mar 10, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Healthy Volunteers Trial in Melbourne (RT-102, Forteo)

Recruiting
  • Healthy Volunteers
  • Melbourne, Australia
    Nucleus Network
Feb 24, 2022

Breast Cancer Trial in China (TQB2102 for injection)

Not yet recruiting
  • Breast Cancer
  • TQB2102 for injection
  • Hefei, Anhui, China
  • +20 more
Nov 1, 2023